| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $41.9M | +81.8% |
| R&D Expense | $91.9M | +11.1% |
| SG&A Expense | $30.3M | +2.9% |
| Operating Income | -$87.5M | +1.7% |
| Pre-tax Income | -$85.5M | +3.4% |
| Income Tax | $0 | — |
| Net Income | -$85.5M | +3.4% |
| EPS (Basic) | -$1.59 | +8.6% |
| EPS (Diluted) | -$1.59 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $63.7M | +373.8% |
| Inventory | $2.4M | -7.8% |
| Current Assets | $168.9M | -2.5% |
| Total Assets | $182.2M | -26.2% |
| Current Liabilities | $23.5M | +33.2% |
| Stockholders' Equity | $158.8M | -30.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$78.7M | -31.0% |
| Capital Expenditures | $43K | +10.3% |
| Investing Cash Flow | $128.7M | +2809.1% |
| Financing Cash Flow | $311K | -99.3% |
| Free Cash Flow | -$78.8M | -31.0% |
| +8.6% |